Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zuqiang Liu

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of Immunological Methods|February 12, 2004
Design and construction of a recombinant epitope-peptide gene as a universal epitope-vaccine strategyZuqiang Liu, Ying-Hua Chen
Immunology Letters|January 1, 2005
Predefined spacers between epitopes on a recombinant epitope-peptide impacted epitope-specific antibody responseZuqiang Liu, Zuguang Wang, Ying-Hua Chen
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2011
Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunityZuqiang Liu, Louis D Falo, Zhaoyang You
Immunobiology|January 30, 2004
Epitope-vaccine strategy against HIV-1: today and tomorrowZuqiang Liu, Yi Xiao, Ying-Hua Chen
Frontiers in Oncology|May 1, 2014
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor ImmunityZong Sheng Guo, Zuqiang Liu, David L Bartlett
Microbiology and Immunology|August 23, 2005
The recombinant immunogen with high-density epitopes of ELDKWA and ELDEWA induced antibodies recognizing both epitopes on HIV-1 gp41Zuguang Wang, Zuqiang Liu, Xiwen Cheng, et al.
Sensors (Basel, Switzerland)|December 17, 2024
Development of Automated 3D LiDAR System for Dimensional Quality Inspection of Prefabricated Concrete ElementsShuangping Li, Bin Zhang, Junxing Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Tumor regulatory T cells potently abrogate antitumor immunityZuqiang Liu, Jin H Kim, Louis D Falo, et al.
Immunology Letters|November 5, 2002
A predefined epitope-specific monoclonal antibody recognizes ELDEWA-epitope just presenting on gp41 of HIV-1 O cladeJin Huang, Xiaonan Dong, Zuqiang Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2009
Therapeutic immunity by adoptive tumor-primed CD4(+) T-cell transfer in combination with in vivo GITR ligationZuqiang Liu, Shenghe Tian, Louis D Falo, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of Immunological Methods|February 12, 2004
Design and construction of a recombinant epitope-peptide gene as a universal epitope-vaccine strategyZuqiang Liu, Ying-Hua Chen
Immunology Letters|January 1, 2005
Predefined spacers between epitopes on a recombinant epitope-peptide impacted epitope-specific antibody responseZuqiang Liu, Zuguang Wang, Ying-Hua Chen
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2011
Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunityZuqiang Liu, Louis D Falo, Zhaoyang You
Immunobiology|January 30, 2004
Epitope-vaccine strategy against HIV-1: today and tomorrowZuqiang Liu, Yi Xiao, Ying-Hua Chen
Frontiers in Oncology|May 1, 2014
Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor ImmunityZong Sheng Guo, Zuqiang Liu, David L Bartlett
Microbiology and Immunology|August 23, 2005
The recombinant immunogen with high-density epitopes of ELDKWA and ELDEWA induced antibodies recognizing both epitopes on HIV-1 gp41Zuguang Wang, Zuqiang Liu, Xiwen Cheng, et al.
Sensors (Basel, Switzerland)|December 17, 2024
Development of Automated 3D LiDAR System for Dimensional Quality Inspection of Prefabricated Concrete ElementsShuangping Li, Bin Zhang, Junxing Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Tumor regulatory T cells potently abrogate antitumor immunityZuqiang Liu, Jin H Kim, Louis D Falo, et al.
Immunology Letters|November 5, 2002
A predefined epitope-specific monoclonal antibody recognizes ELDEWA-epitope just presenting on gp41 of HIV-1 O cladeJin Huang, Xiaonan Dong, Zuqiang Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2009
Therapeutic immunity by adoptive tumor-primed CD4(+) T-cell transfer in combination with in vivo GITR ligationZuqiang Liu, Shenghe Tian, Louis D Falo, et al.
Pageof 8